LAVAL, Québec--(BUSINESS WIRE)--BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations, co-organizers of Sweet Biopharma Day, are pleased to announce that Epitopea, represented by Steven Klein, is the winner of the 2023 edition. Sixteen Canadian startup companies (“Sweet 16”) selected by representatives from global pharma companies, made an elevator pitch in front of 120+ participants, who voted for Epitopea as the winner of Sweet Biopharma Day 2023 and of the $2,500 grand prize.
This year, the in-person event was under the sweet flavour of the maple and hosted in a traditional sugar shack in the Quebec province. Twenty-nine proposals were received and the selected Sweet 16 presented innovative and disruptive life science technologies all with the same intent of improving patients’ quality of life and finding cures for diseases.
"adMare is proud to support this event that highlights the high-quality research being conducted in Canada as well as the expertise and high potential of our biotechnology entrepreneurs. This day is an excellent opportunity to discover promising therapeutic innovations and encourage their development," says Mounia Azzi, Vice President of Corporate Development, adMare BioInnovations.
"We are excited to be back for this 3rd edition of Sweet Biopharma Day. CQDM is proud to bring together our pharmaceutical partners and the innovative Canadian companies of the 'Sweet 16' to network and initiate discussions that may lead to future strategic collaborations and partnerships," adds Jesse Paterson, Senior Director, Business Development, CQDM.
“At the Fonds de solidarité FTQ, we are proud to have supported Sweet Biopharma Day since its launch in 2019. Such events are important as various actors from the life sciences industry get to meet innovative companies that develop new treatments for unmet medical needs and help improve patients’ health,” noted Geneviève Guertin, Vice-President, Private Equity and Impact Investing, Life Sciences, at the Fonds de solidarité FTQ.
Anie Perrault, Consultant, BIOQuébec concludes: "We are really proud to have allowed key players in the life sciences ecosystem in Quebec, Canada and internationally to come together to discuss, create new links, foster new collaborations and accelerate the development of new biopharmaceutical innovations."
The Sweet Biopharma Day was generously financially supported by its Gold sponsor, Fonds de solidarité FTQ, its Silver sponsors, Innovative Medicines Canada, adMare BioInnovations, RBCx, Investissement Québec, Robic, CQIB and Mispro Biotech Services, its Bronze sponsors Giiant Pharma, Inversago , Amorchem, CTI Fonds Sciences de la vie, Thermo Fisher Scientific and Agilent, and Maple sponsors RBCx, BIOTECanada and Sciex.
About Sweet Biopharma Day
The Sweet Biopharma Day is a Canadian life sciences event. Its third edition is being organized by BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations. It provides executives from young biotech companies with a unique opportunity to directly interact with international pharmaceutical companies and key venture capital firms to develop synergistic partnerships.
Visit Sweet Biopharma Day website HERE.
